The FDA has approved a new drug treatment for a type of brain cancer called low-grade glioma. The drug, called vorasidenib, is a targeted cancer… Read More »FDA Approves Drug Targeting Johns Hopkins-Discovered Brain Cancer Gene Mutation
Bert Vogelstein, M.D., ranks today, as he has for more than three decades, as the pre-eminent international scientist. The discoveries that led the world to understand that cancer… Read More »Bert Vogelstein: Internationally Renowned Cancer Researcher
In the latest Cancer Matters podcast, Dr Bill Nelson speaks with Dr Bert Vogelstein about shifting his work as a cancer researcher to detecting and… Read More »Cancer Matters with Dr Bill Nelson – Preventing the Spread of COVID-19
A new mathematical model of tumorigenesis—the formation of cancer—developed by scientists at the Johns Hopkins Kimmel Cancer Center, Whiting School of Engineering, and Bloomberg School… Read More »New Mathematical Model of Cancer Formation Reveal that Genetic Signs of the Disease Can Start Decades Before Diagnosis
About ten years ago, researcher Bert Vogelstein appeared with Katie Couric on the Today Show to announce new research on a stool test for colon… Read More »A Prize, Promotion and Press Story